Inflamm Bowel Dis:武汉炎性肠病(IBD)的流行病学调查

2013-08-23 MedSci MedSci原创

西方国家炎性肠病(IBD)的发病率较高,在中国的发病率比较低,但现在随着时间推移IBD在中的发病率也逐渐升高。不过目前中国IBD的发病率还 不明确。为此来自武汉大学中南医院的JieZhao等人进行一项研究,该研究结果发表在8月份的Inflammatory Bowel Diseases上,研究主要是通过以普通人群为基础的方法调查武汉市的IBD发病率及该人群中IBD的临床表型。 这是一项前

西方国家炎性肠病(IBD)的发病率较高,在中国的发病率比较低,但现在随着时间推移IBD在中的发病率也逐渐升高。不过目前中国IBD的发病率还 不明确。为此来自武汉大学中南医院的JieZhao等人进行一项研究,该研究结果发表在8月份的Inflammatory Bowel Diseases上,研究主要是通过以普通人群为基础的方法调查武汉市的IBD发病率及该人群中IBD的临床表型。

这是一项前瞻性研究,研究时间从2010年1月到2010年12月份止。新的IBD病例来自由胃肠病学家的诊断及覆盖武汉中心的17家医院的记录。 这些新确诊的病人由一IBD专家小组进行随访,并且每3个月进行一次病情的评估。这个研究中的危险人群总数为6085556人。研究发现,在这1年内新确 诊的IBD共有131例,其中UC97例,34例是CD,总的IBD、UC和CD标准化发病率分别为1.96/10万和1.45/10万及0.51/10 万。这些病人中,CD仅有15%累及小肠,累及结肠的为24%,累及回结肠处的达61%.同时,CD和UC还有不同的临床表型:CD以炎症为主的44%, 肠腔狭窄占29%,透壁性损伤24%;UC以直肠炎为主的34.5%,左半结肠炎占44.6%,广泛结肠炎19.5%.研究认为,武汉的IBD的发病率在 中国算是较高的。虽然仍然比西方国家的发病率低,但在中国这样一个IBD发病率逐年增加的国家,我们需要对新发的IBD患者给予特殊的医疗服务及教育,并 确定一些可能的致病因素以预防IBD的发生

原始出处:

Zhao J, Ng SC, Lei Y, Yi F, Li J, Yu L, Zou K, Dan Z, Dai M, Ding Y, Song M, Mei Q, Fang X, Liu H, Shi Z, Zhou R, Xia M, Wu Q, Xiong Z, Zhu W, Deng L, Kamm MA, Xia B.First Prospective, Population-Based Inflammatory Bowel Disease Incidence Study in Mainland of China: The Emergence of "Western" Disease.Inflamm Bowel Dis. 2013 Aug;19(9):1839-1845

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2011845, encodeId=857e2011845e8, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 10 21:02:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057568, encodeId=9208205e5687a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Jan 16 06:02:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977410, encodeId=5a3c19e7410c9, content=<a href='/topic/show?id=57613630b9' target=_blank style='color:#2F92EE;'>#Bow#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3630, encryptionId=57613630b9, topicName=Bow)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Mon Aug 26 01:02:00 CST 2013, time=2013-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263407, encodeId=cfb7126340ee3, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411201, encodeId=4c511411201cf, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423780, encodeId=3c201423e8026, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454798, encodeId=e4be1454e987e, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512663, encodeId=fd381512663bf, content=<a href='/topic/show?id=070d36311d' target=_blank style='color:#2F92EE;'>#bowel#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3631, encryptionId=070d36311d, topicName=bowel)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5b610492692, createdName=ms2536978994064944, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2011845, encodeId=857e2011845e8, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 10 21:02:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057568, encodeId=9208205e5687a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Jan 16 06:02:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977410, encodeId=5a3c19e7410c9, content=<a href='/topic/show?id=57613630b9' target=_blank style='color:#2F92EE;'>#Bow#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3630, encryptionId=57613630b9, topicName=Bow)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Mon Aug 26 01:02:00 CST 2013, time=2013-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263407, encodeId=cfb7126340ee3, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411201, encodeId=4c511411201cf, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423780, encodeId=3c201423e8026, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454798, encodeId=e4be1454e987e, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512663, encodeId=fd381512663bf, content=<a href='/topic/show?id=070d36311d' target=_blank style='color:#2F92EE;'>#bowel#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3631, encryptionId=070d36311d, topicName=bowel)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5b610492692, createdName=ms2536978994064944, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=)]
    2014-01-16 lxg951
  3. [GetPortalCommentsPageByObjectIdResponse(id=2011845, encodeId=857e2011845e8, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 10 21:02:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057568, encodeId=9208205e5687a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Jan 16 06:02:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977410, encodeId=5a3c19e7410c9, content=<a href='/topic/show?id=57613630b9' target=_blank style='color:#2F92EE;'>#Bow#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3630, encryptionId=57613630b9, topicName=Bow)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Mon Aug 26 01:02:00 CST 2013, time=2013-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263407, encodeId=cfb7126340ee3, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411201, encodeId=4c511411201cf, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423780, encodeId=3c201423e8026, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454798, encodeId=e4be1454e987e, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512663, encodeId=fd381512663bf, content=<a href='/topic/show?id=070d36311d' target=_blank style='color:#2F92EE;'>#bowel#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3631, encryptionId=070d36311d, topicName=bowel)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5b610492692, createdName=ms2536978994064944, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=)]
    2013-08-26 yuandd
  4. [GetPortalCommentsPageByObjectIdResponse(id=2011845, encodeId=857e2011845e8, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 10 21:02:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057568, encodeId=9208205e5687a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Jan 16 06:02:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977410, encodeId=5a3c19e7410c9, content=<a href='/topic/show?id=57613630b9' target=_blank style='color:#2F92EE;'>#Bow#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3630, encryptionId=57613630b9, topicName=Bow)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Mon Aug 26 01:02:00 CST 2013, time=2013-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263407, encodeId=cfb7126340ee3, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411201, encodeId=4c511411201cf, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423780, encodeId=3c201423e8026, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454798, encodeId=e4be1454e987e, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512663, encodeId=fd381512663bf, content=<a href='/topic/show?id=070d36311d' target=_blank style='color:#2F92EE;'>#bowel#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3631, encryptionId=070d36311d, topicName=bowel)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5b610492692, createdName=ms2536978994064944, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=)]
    2013-08-25 bnurmamat
  5. [GetPortalCommentsPageByObjectIdResponse(id=2011845, encodeId=857e2011845e8, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 10 21:02:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057568, encodeId=9208205e5687a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Jan 16 06:02:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977410, encodeId=5a3c19e7410c9, content=<a href='/topic/show?id=57613630b9' target=_blank style='color:#2F92EE;'>#Bow#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3630, encryptionId=57613630b9, topicName=Bow)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Mon Aug 26 01:02:00 CST 2013, time=2013-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263407, encodeId=cfb7126340ee3, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411201, encodeId=4c511411201cf, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423780, encodeId=3c201423e8026, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454798, encodeId=e4be1454e987e, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512663, encodeId=fd381512663bf, content=<a href='/topic/show?id=070d36311d' target=_blank style='color:#2F92EE;'>#bowel#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3631, encryptionId=070d36311d, topicName=bowel)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5b610492692, createdName=ms2536978994064944, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=)]
    2013-08-25 xugumin
  6. [GetPortalCommentsPageByObjectIdResponse(id=2011845, encodeId=857e2011845e8, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 10 21:02:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057568, encodeId=9208205e5687a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Jan 16 06:02:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977410, encodeId=5a3c19e7410c9, content=<a href='/topic/show?id=57613630b9' target=_blank style='color:#2F92EE;'>#Bow#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3630, encryptionId=57613630b9, topicName=Bow)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Mon Aug 26 01:02:00 CST 2013, time=2013-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263407, encodeId=cfb7126340ee3, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411201, encodeId=4c511411201cf, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423780, encodeId=3c201423e8026, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454798, encodeId=e4be1454e987e, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512663, encodeId=fd381512663bf, content=<a href='/topic/show?id=070d36311d' target=_blank style='color:#2F92EE;'>#bowel#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3631, encryptionId=070d36311d, topicName=bowel)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5b610492692, createdName=ms2536978994064944, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2011845, encodeId=857e2011845e8, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 10 21:02:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057568, encodeId=9208205e5687a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Jan 16 06:02:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977410, encodeId=5a3c19e7410c9, content=<a href='/topic/show?id=57613630b9' target=_blank style='color:#2F92EE;'>#Bow#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3630, encryptionId=57613630b9, topicName=Bow)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Mon Aug 26 01:02:00 CST 2013, time=2013-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263407, encodeId=cfb7126340ee3, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411201, encodeId=4c511411201cf, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423780, encodeId=3c201423e8026, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454798, encodeId=e4be1454e987e, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512663, encodeId=fd381512663bf, content=<a href='/topic/show?id=070d36311d' target=_blank style='color:#2F92EE;'>#bowel#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3631, encryptionId=070d36311d, topicName=bowel)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5b610492692, createdName=ms2536978994064944, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=)]
    2013-08-25 xiaoyeshuang
  8. [GetPortalCommentsPageByObjectIdResponse(id=2011845, encodeId=857e2011845e8, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 10 21:02:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057568, encodeId=9208205e5687a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10672, encryptionId=c02b106e29a, topicName=LAM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04ce158, createdName=lxg951, createdTime=Thu Jan 16 06:02:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977410, encodeId=5a3c19e7410c9, content=<a href='/topic/show?id=57613630b9' target=_blank style='color:#2F92EE;'>#Bow#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3630, encryptionId=57613630b9, topicName=Bow)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Mon Aug 26 01:02:00 CST 2013, time=2013-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263407, encodeId=cfb7126340ee3, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411201, encodeId=4c511411201cf, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423780, encodeId=3c201423e8026, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1454798, encodeId=e4be1454e987e, content=<a href='/topic/show?id=ca5f12e51d4' target=_blank style='color:#2F92EE;'>#NFL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12751, encryptionId=ca5f12e51d4, topicName=NFL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90805606164, createdName=xiaoyeshuang, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512663, encodeId=fd381512663bf, content=<a href='/topic/show?id=070d36311d' target=_blank style='color:#2F92EE;'>#bowel#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3631, encryptionId=070d36311d, topicName=bowel)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5b610492692, createdName=ms2536978994064944, createdTime=Sun Aug 25 01:02:00 CST 2013, time=2013-08-25, status=1, ipAttribution=)]

相关资讯

AP&T:炎性肠病成年患者BMI明显下降

关于炎性肠病(IBD)患者的身体成分组成资料很少。脂肪和肌肉成分的改变可能影响骨骼健康、肌肉性能、生活质量及整体发病率。来自美国的R. V. Bryant、M. J. Trott近日发表论文,该研究系统回顾与IBD成年患者身体成分组成相关的文献,并探讨其中潜在的促成因素及相互关系。研究显示,目前的资料,尽管多种多样,都表明许多IBD患者其脂肪组织和肌肉组织的

炎性肠病治疗研究2010年度进展

                                        

DCR:术前应用英夫利昔单抗不增加炎性肠病患者腹腔镜下切除后死亡率

  近日,《结肠与直肠疾病》(Diseases of the Colon & Rectum)杂志载文评价了英夫利昔单抗对在接受择期腹腔下切除术的炎性肠病(IBD)患者围术期转归的影响。文章发表于2013年第56卷第4期。   该文作者Mukta Krane对经过伦理委员会批准后前瞻性收集的数据库进行了回顾性分析。   该团队对

GUT:炎性肠病与生活方式相关

  近日,一项关于多个国家和地区的研究指出,炎性肠病(IBD)随时间及地理而变化的流行病学提示环境因素在疾病表达的改变中发挥重要作用。该疾病在发展中国家的出现提示流行病学进展与西方化的生活方式以及工业化相关。该文发表在2013年第63卷第4期《消化道》(GUT)杂志上。   来自香港的Siew Ng医师指出,已发现的最强的环境相关因素为吸烟和阑尾切除,不过两种因素均不足以单独解释

Science:肠道中硝酸盐能促进大肠杆菌生长,加重炎性肠病

    一直以来科学家们都有一个困扰:那些有害的细菌,如大肠杆菌,为什么会在炎症性肠病患者的肠道内大肆生长,并引起严重的腹泻呢。如今,UC Davis 的研究员们找到了答案,而这意味着我们在更好地治疗炎症性肠病的道路上迈出了第一步。     研究员们发现了一种生物学机制,在这种机制下有害细菌在炎症性肠病患者体内生长,逐步排挤有益细菌,并